Briefing
Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA.
TRACERx developed ctDNA methods tracking a median of 200 mutations from resected non-small cell lung cancer across 1,069 plasma samples to study early metastatic dissemination. The abstract does not name a commercial assay.
- Design: Evidence level 2
- Assay: Not named in the abstract